Cell Corp Gc serves as Executive at Artiva Biotherapeutics, Inc., where they oversee executive responsibilities. Since joining the company, Cell Corp Gc has executed 8 insider transactions totaling $25.0M, demonstrating a bullish approach to their equity position. Their most recent transaction on Jul 22, 2024 involved exercising options for 667,185 shares valued at $0.
Cell Corp Gc currently holds 1,016,022 shares of Artiva Biotherapeutics, Inc. (ARTV), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Cell Corp Gc has been a net buyer of ARTV stock. They have purchased $25.0M and sold $0 worth of shares.
Cell Corp Gc's most recent insider trade was on Jul 22, 2024, when they sold 667,185 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Jul 22, 2024 | ARTV | $3.0M | Other | 294,117 | $10.20 | Discretionary |
| Jul 22, 2024 | ARTV | $20.0M | Purchase | 1,666,666 | $12.00 | Discretionary |
| Jul 22, 2024 | ARTV | $0 | Conversion | 292,791 | $N/A | Discretionary |
| Jul 22, 2024 | ARTV | $0 | Conversion | 62,181 | $N/A | Discretionary |
| Jul 22, 2024 | ARTV | $2.6M | Other | 256,316 | $10.20 | Discretionary |
| Jul 22, 2024 | ARTV | $5.0M | Purchase | 416,666 | $12.00 | Discretionary |